High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Année : 2017

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.

(1) , (2) , (3) , (4) , (1) , (5) , (6) , (7) , (7) , (8, 9) , (10) , (11) , (2) , (12) , (13)
1
2
3
4
5
6
7
8
9
10
11
12
13

Résumé

Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.

Dates et versions

hal-01516289 , version 1 (30-04-2017)

Identifiants

Citer

Anton W Langerak, Monika Brüggemann, Frédéric Davi, Nikos Darzentas, Jacques J M van Dongen, et al.. High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.. Journal of Immunology, 2017, pp.1602050. ⟨10.4049/jimmunol.1602050⟩. ⟨hal-01516289⟩
324 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More